4-Toluenesulfonylureido derivatives of amines, amino acids and dipeptides: a novel class of potential antitumor agents

Branda, 1988, Cellular pharmacology of chloroquinoxaline sulfonamide and a related compound in murine B16 melanoma cells, Biochem. Pharmacol., 37, 4557, 10.1016/0006-2952(88)90672-7 Briganti, 1999, Novel carbonic anhydrase isozymes I, II and IV activators incorporating sulfonyl-histamino moieties, Bioorg. Med. Chem. Lett., 9, 2043, 10.1016/S0960-894X(99)00310-8 Chern, 1997, Synthesis and cytotoxic evaluation of substituted sulfonyl-N-hydroxyguanidine derivatives as potential antitumor agents, J. Med. Chem., 40, 2276, 10.1021/jm9607818 Ehlhardt, 1991, Metabolism and disposition of the anticancer agent sulofenur in rat, mouse, monkey and human, Drug Metab. Dispos., 19, 370 Fields, 1990, Solid phase peptide synthesis utilizing 9-fluorenylmethoxycarbonyl amino acids, Int. J. Protein Res., 35, 161, 10.1111/j.1399-3011.1990.tb00939.x Flygare, J., Medina, J.C., Shan, B., Clark, D.L., Rosen, T., 1998. Pentafluorobenzenesulfonamides and analogs. WO 98/05315. Houghton, 1996, Antitumor diarylsulfonylureas: novel agents with unfulfilled promise, Invest. New Drugs, 14, 271, 10.1007/BF00194530 Howbert, 1990, Novel agents effective against solid tumors: the diarylsulfonylureas. Synthesis, activities, and analysis of quantitative structure–activity relationships, J. Med. Chem., 33, 2393, 10.1021/jm00171a013 Medina, 1999, Novel halogenated sulfonamides inhibit the growth of multidrug resistant MCF-7/ADR cancer cells, Bioorg. Med. Chem. Lett., 9, 1843, 10.1016/S0960-894X(99)00276-0 Medina, 1998, Novel antineoplastic agents with efficacy against multidrug resistant tumor cells, Bioorg. Med. Chem. Lett., 8, 2653, 10.1016/S0960-894X(98)00477-6 Mohamadi, 1992, Sulfonylureas: a new class of cancer chemotherapeutic agents, J. Med. Chem., 35, 3012, 10.1021/jm00094a013 Owa, 1999, Discovery of novel antitumor sulfonamides targeting G1 phase of the cell cycle, J. Med. Chem., 42, 3789, 10.1021/jm9902638 Rigas, 1995, Clinical and pharmacology study of chloroquinoxaline sulfonamide given on a weekly schedule, Cancer Chemother. Pharmacol., 35, 483, 10.1007/BF00686832 Rush, 1992, Effects of diarylsulfonylurea antitumor agents on the function of mitochondria isolated from rat liver and GC3/c1 cells, Biochem. Pharmacol., 44, 2387, 10.1016/0006-2952(92)90684-B Scozzafava, 1999, Carbonic anhydrase inhibitors. Part 74. Synthesis of water-soluble, topically effective intraocular pressure lowering aromatic/heterocyclic sulfonamides containing cationic or anionic moieties: is the tail more important than the ring?, J. Med. Chem., 42, 2641, 10.1021/jm9900523 Scozzafava, 1999, Carbonic anhydrase inhibitors: synthesis of water-soluble, amino acyl/dipeptidyl sulfonamides possessing long-lasting intraocular pressure-lowering properties via the topical route, J. Med. Chem., 42, 3690, 10.1021/jm9901879 Scozzafava, 1999, Carbonic anhydrase inhibitors. Part 66. Arylsulfonylureido and arylureido-substituted aromatic and heterocyclic sulfonamides: towards selective inhibitors of carbonic anhydrase isozyme I, J. Enzyme Inhib., 14, 343, 10.3109/14756369909030328 Scozzafava, 2000, Carbonic anhydrase inhibitors: synthesis of N-morpholyl-thiocarbonylsulfenylamino aromatic/heterocyclic sulfonamides and their interaction with isozymes I, II and IV, Bioorg. Med. Chem. Lett., 10, 1117, 10.1016/S0960-894X(00)00178-5 Scozzafava, 2000, Carbonic anhydrase activators. Part 24. High affinity isozymes I, II and IV activators, derivatives of 4-(4-chlorophenylsulfonylureido-amino acyl)ethyl-1H-imidazole, Eur. J. Pharm. Sci., 10, 29, 10.1016/S0928-0987(99)00086-X Scozzafava, 2000, Protease inhibitors: synthesis of potent matrix metalloproteinase and bacterial collagenase inhibitors incorporating N-4-nitrobenzylsulfonyl glycine hydroxamate moieties, J. Med. Chem., 42, 1858, 10.1021/jm990594k Sirotnak, 2000, Markedly decreased binding of vincristine to tubulin in vinca alkaloid-resistant Chinese hamster cells is associated with selective overexpression of alpha and beta tubulin isoforms, Biochem. Biophys. Res. Commun., 269, 21, 10.1006/bbrc.2000.2246 Sosinski, 1994, Cross-resistance to antitumor diarylsulfonylureas and collateral sensitivity to mitochondrial toxins in a human cell line selected for resistance to the antitumor agent N-(5-indanylsulfonyl)-N′-(4-chlorophenyl)urea, Mol. Pharmacol., 45, 962 Supuran, C.T., Briganti, F., Tilli, S., Chegwidden, R., Scozzafava, A., 2000. Carbonic anhydrase inhibitors: sulfonamides as antitumor drugs? J. Med. Chem. (in press). Supuran, 2000, Carbonic anhydrase inhibitors and their therapeutic potential, Exp. Opin. Ther. Patents, 10, 575, 10.1517/13543776.10.5.575 1997, 7 Toth, 1997, Sulfonimideamide analogs of oncolytic sulfonylureas, J. Med. Chem., 40, 1018, 10.1021/jm960673l Ulrich, 1965, The chemistry of sulfonyl isocyanates, Chem. Rev., 65, 369, 10.1021/cr60235a002 Yoshino, 1992, Novel sulfonamides as potential systemically active antitumor agents, J. Med. Chem., 35, 2496, 10.1021/jm00091a018